![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 471/04 | (2006.01) |
A61K 31/437 | (2006.01) | ||
A61P 37/00 | (2006.01) |
(11) | Number of the document | 3510033 |
(13) | Kind of document | T |
(96) | European patent application number | 17777966.7 |
Date of filing the European patent application | 2017-09-06 | |
(97) | Date of publication of the European application | 2019-07-17 |
(45) | Date of publication and mention of the grant of the patent | 2021-11-24 |
(46) | Date of publication of the claims translation | 2022-02-25 |
(86) | Number | PCT/IB2017/055375 |
Date | 2017-09-06 |
(87) | Number | WO 2018/047081 |
Date | 2018-03-15 |
(30) | Number | Date | Country code |
201662385726 P | 2016-09-09 | US |
(72) |
ALPER, Phillip , US
DEANE, Jonathan , US
JIANG, Songchun , US
JIANG, Tao , US
KNOEPFEL, Thomas , CH
MICHELLYS, Pierre-Yves , US
MUTNICK, Daniel , US
PEI, Wei , US
SYKA, Peter , US
ZHANG, Guobao , CN
ZHANG, Yi , US
|
(73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Junginiai ir kompozicijos kaip endosominių Toll tipo receptorių inhibitoriai |
COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS |
Payment date | Validity (years) | Amount | |
2024-08-20 | 8 | 185.00 EUR |
2025-09-06 |